Cargando…
Preclinical Testing of an Oncolytic Parvovirus in Ewing Sarcoma: Protoparvovirus H-1 Induces Apoptosis and Lytic Infection In Vitro but Fails to Improve Survival In Vivo
About 70% of all Ewing sarcoma (EWS) patients are diagnosed under the age of 20 years. Over the last decades little progress has been made towards finding effective treatment approaches for primarily metastasized or refractory Ewing sarcoma in young patients. Here, in the context of the search for n...
Autores principales: | Lacroix, Jeannine, Kis, Zoltán, Josupeit, Rafael, Schlund, Franziska, Stroh-Dege, Alexandra, Frank-Stöhr, Monika, Leuchs, Barbara, Schlehofer, Jörg R., Rommelaere, Jean, Dinsart, Christiane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024310/ https://www.ncbi.nlm.nih.gov/pubmed/29865280 http://dx.doi.org/10.3390/v10060302 |
Ejemplares similares
-
Preclinical Testing of an Oncolytic Parvovirus: Standard Protoparvovirus H-1PV Efficiently Induces Osteosarcoma Cell Lysis In Vitro
por: Geiss, Carsten, et al.
Publicado: (2017) -
Pediatric and Adult High-Grade Glioma Stem Cell Culture Models Are Permissive to Lytic Infection with Parvovirus H-1
por: Josupeit, Rafael, et al.
Publicado: (2016) -
Oncolytic effects of parvovirus H-1 in medulloblastoma are associated with repression of master regulators of early neurogenesis
por: Lacroix, Jeannine, et al.
Publicado: (2014) -
Immune System Stimulation by Oncolytic Rodent Protoparvoviruses
por: Angelova, Assia, et al.
Publicado: (2019) -
Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1
por: Moehler, Markus, et al.
Publicado: (2011)